Outcome Reporting Bias in Randomized Clinical Trials: A Literature Review
Randomized controlled trials (RCTs) are fundamental to evidence-based medicine; however, their reliability depends on the complete, accurate, and transparent reporting of study outcomes.Outcome reporting bias (ORB), including selective outcome reporting (SOR) and outcome switching, can distort interpretations of treatment efficacy and safety by selectively omitting, modifying, or emphasizing findings based on direction or statistical significance.This literature review examines the manifestations, prevalence, contributing factors, and consequences of ORB in RCTs, with particular emphasis on SOR and outcome switching.Evidence from systematic reviews and cross-sectional studies demonstrates that discrepancies between prospectively specified and published outcomes remain common, affecting approximately one-third of trials in broad assessments.Although such discrepancies do not necessarily indicate reporting bias, undisclosed or inadequately justified modifications undermine transparency and hinder independent evaluation of trial findings.Despite the widespread adoption of prospective trial registration and established reporting guidelines, persistent inconsistencies highlight the limitations of existing safeguards.Strengthening these practices is essential to improve the reliability of RCT evidence by reducing reporting bias and preserving the integrity of clinical research.
Authors
- Edward Lewis Tobinick (ORCID: https://orcid.org/0000-0001-7614-499X)
- Danielle Ucci
- Samantha Asseraf
- Genavieve Prieto
Institutions
- Neurological Recovery House (US)
Publication Details
- Journal
- Cureus
- Published
- 2026-11-13
- DOI
- https://doi.org/10.7759/cureus.119604
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00